Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

Press releases published on October 19, 2026

Oct. 19, 2026

BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026

Indeterminate GlobeNewswire

Oct. 19, 2026

Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site

Indeterminate GlobeNewswire

Oct. 19, 2026

Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany

Indeterminate GlobeNewswire

Oct. 19, 2026

Communiqué de presse : Sanofi pose la première pierre d’une nouvelle unité de production d’insuline de pointe en Allemagne

Indeterminate GlobeNewswire

Oct. 19, 2026

Quanta Therapeutics Announces Presentation of QTX3034 Clinical Combination Data with Anti-EGFR and Chemotherapy in Colorectal Cancer (CRC) at ESMO and Fast Track Designation for Patients with KRAS G12D Mutations

Indeterminate GlobeNewswire

Oct. 19, 2026

Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma

Indeterminate GlobeNewswire

Oct. 19, 2026

Belite Bio Announces Uplisting to the Nasdaq Global Select Market

Indeterminate GlobeNewswire

Oct. 19, 2026

Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers

Indeterminate GlobeNewswire

Oct. 19, 2026

TLC590 Achieves Statistically Significant Reductions in Pain and Opioid Use Versus Both Placebo and Liposomal Bupivacaine in Pivotal Phase 3 Trial

Indeterminate GlobeNewswire

Oct. 19, 2026

Prime Minister Mark Carney Sends Greetings as Canada Lights Up Sea-foam Green for International Stuttering Awareness Day

Indeterminate GlobeNewswire

Oct. 19, 2026

Evaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01

Indeterminate GlobeNewswire

Oct. 19, 2026

Nouscom Raises €120 Million ($135 Million) in Oversubscribed Series D Financing and will Present Long-Term Cancer Interception Clinical Data in Lynch Syndrome Carriers at ESMO

Indeterminate GlobeNewswire

Oct. 19, 2026

Oculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Disease

Indeterminate GlobeNewswire

Oct. 19, 2026

OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

Oct. 19, 2026

OSE Immunotherapeutics annonce les résultats de Topline positifs de l'étude de Phase 2 randomisée Combi-TED de Tedopi® (OSE2101) dans le cancer du poumon non à petites cellules métastatique

Indeterminate GlobeNewswire

Oct. 19, 2026

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

Indeterminate GlobeNewswire

Oct. 19, 2026

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

Indeterminate GlobeNewswire

Oct. 19, 2026

JJP Biologics Doses the First Patients in Phase 1b Clinical Trial of Nebaprubart in Rheumatoid Arthritis (RA)

Indeterminate GlobeNewswire

Oct. 19, 2026

Intelligent Scopes Unveils the ISC 100: The Solution Enabling Urology AI to Work Beside Any Cystoscopy Tower — No Replacement, No Rewiring, No Cloud

Indeterminate GlobeNewswire